−15.88 MEUR
6.75 M
About ACTICOR BIOTECH
Sector
Industry
CEO
Gilles Avenard
Website
Headquarters
Paris
Employees (FY)
21
Founded
2013
ISIN
FR0014005OJ5
FIGI
BBG0131M76J1
Acticor Biotech SAS engages in the research and development of an antithrombotic agent for the treatment of the acute thrombotic diseases. It specializes on ischemic stroke. The company was founded on November 26, 2013 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALACT is 3.80 EUR — it has decreased by 0.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ACTICOR BIOTECH stocks are traded under the ticker ALACT.
ACTICOR BIOTECH is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
ALACT stock is 0.53% volatile and has beta coefficient of 1.10. Check out the list of the most volatile stocks — is ACTICOR BIOTECH there?
One year price forecast for ACTICOR BIOTECH has a max estimate of 10.00 EUR and a min estimate of 10.00 EUR.
Yes, you can track ACTICOR BIOTECH financials in yearly and quarterly reports right on TradingView.
ALACT stock has risen by 1.88% compared to the previous week, the month change is a 26.25% rise, over the last year ACTICOR BIOTECH has showed a 34.48% decrease.
Today ACTICOR BIOTECH has the market capitalization of 60.19 M, it has decreased by 0.29% over the last week.
No, ALACT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALACT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTICOR BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 21.00 employees. See our rating of the largest employees — is ACTICOR BIOTECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACTICOR BIOTECH technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACTICOR BIOTECH stock shows the sell signal. See more of ACTICOR BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ACTICOR BIOTECH future price: according to them, ALACT price has a max estimate of 10.00 EUR and a min estimate of 10.00 EUR. Read a more detailed ACTICOR BIOTECH forecast: see what analysts think of ACTICOR BIOTECH and suggest that you do with its stocks.